BNT-113

N/A

Report date: 2026/05/13 15:37:23

Base Information

Drug NameBNT-113
Drug Alias NameE6/E7 RNA(LIP)HPV Anti-CD40 RNA VaccineRBLO 15.1(LIP)/RBLO 16.1(LIP)HPV mRNA vaccine (BioNTech)BNT 113 +[6] 
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsNeoplasms, Unknown PrimaryPenile NeoplasmsUterine Cervical Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[22] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesBiontech Se
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of SouthamptonBiontech Se
Inactive CompaniesN/A
Active IndicationsNeoplasms, Unknown PrimaryPenile NeoplasmsUterine Cervical Neoplasms +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A